Introduction: Mutation in lung adenocarcinoma pose significant challenges in lung malignancy management. Next‑generation sequencing can reveal uncommon variants and drug‑resistance mechanisms that require personalized therapy.
Case: First case, 68 years old female diagnosed with lung nodules since 2021 without regular...
Hendro Suryadi, U. Setyawan, Y. Sugiri et al.· Jurnal Respirasi· 0 citations
Introduction: Breast cancer often metastasizes to bone, liver, and lungs, while endobronchial metastasis (EBM) is rare, accounting for only 2–28% of cases and is exceptionally uncommon when bilateral.
Case Presentation: We report a 37-year-old woman with stage IV breast cancer who developed bilateral endobronchial meta...
Fibrianti Ratnasari, U. Setyawan, Christian Surya Eka Putra et al.· Indonesian Journal of Cancer· 0 citations
Introduction: Rhabdomyosarcoma (RMS) is a malignant tumor that develops from mesenchymal cells, very rare in adults, approximately only 1-2%. Sclerosing Rhabdomyosarcoma (ScRMS) includes as newer subtypes of RMS, forming 5-10% of all RMS cases. RMS very rare occurs in the mediastinal, the predilection generally in extr...
Ria Christin Lumpiach, Y. Sugiri, U. Setyawan et al.· Jurnal Respirasi· 0 citations
Metabolic syndrome (MetS) may contribute to pulmonary fibrotic remodeling through metabolic dysregulation, oxidative stress, and inflammatory signaling. Epigallocatechin gallate (EGCG) and chlorogenic acid (CGA) have antioxidant, anti-inflammatory, and metabolic regulatory properties, but their combined effects on syst...
Gregorio S. Pinunggul, Susanthy Djajalaksana, S. Pratiwi et al.· Narra J· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
